We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
Cap. Flow
-$892M
Cap. Flow %
-2.66%
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
NUS icon
Nu Skin
NUS
+$123M
2
DAN icon
Dana Inc
DAN
+$61.6M
3
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
+$55.3M
4
CVEO icon
Civeo
CVEO
+$37.3M
5
PLUS icon
ePlus
PLUS
+$30M

Sector Composition

Rank Sector Weight
1 Industrials 24.45%
2 Technology 18.1%
3 Consumer Discretionary 14.79%
4 Financials 9.92%
5 Materials 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FAF icon
801
First American
FAF
$6.65B
$6.29M 0.02%
226,361
-23,200
-9% -$633K
2013 Q2
4 quarters
WU icon
802
Western Union
WU
$1.92B
$6.27M 0.02%
361,400
– –
2013 Q2
4 quarters
ZAGG
803
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$6.22M 0.02%
1,144,991
-240,000
-17% -$1.11M
2013 Q2
4 quarters
GFI icon
804
Gold Fields
GFI
$33.4B
$6.21M 0.02%
1,668,400
+210,000
+14% +$808K
2013 Q2
4 quarters
PRLB icon
805
Protolabs
PRLB
$2.06B
$6.15M 0.02%
75,110
– –
2013 Q2
4 quarters
HGT
806
DELISTED
Hugoton Royalty Trust
HGT
$6.13M 0.02%
558,500
– –
2013 Q2
4 quarters
TRIB
807
Trinity Biotech
TRIB
$6.88M
$6.1M 0.02%
1,767
-92
-5% -$327K
2013 Q2
4 quarters
DCO icon
808
Ducommun
DCO
$2.56B
$6.09M 0.02%
233,000
– –
2013 Q2
4 quarters
ALV icon
809
Autoliv
ALV
$8.42B
$6.06M 0.02%
78,954
-32,738
-29% -$2.45M
2013 Q2
4 quarters
AXTI icon
810
AXT Inc
AXTI
$3.5B
$6.05M 0.02%
2,826,589
-389,826
-12% -$852K
2013 Q2
4 quarters
WTW icon
811
Willis Towers Watson
WTW
$29.1B
$6.04M 0.02%
52,624
-5,436
-9% -$612K
2013 Q2
4 quarters
MOS icon
812
The Mosaic Company
MOS
$5.98B
$6.01M 0.02%
121,500
-5,000
-4% -$246K
2013 Q2
4 quarters
ECOL
813
DELISTED
US Ecology, Inc.
ECOL
$6.01M 0.02%
122,705
-37,000
-23% -$1.7M
2013 Q2
4 quarters
KEX icon
814
Kirby Corp
KEX
$7.17B
$5.95M 0.02%
50,800
– –
2013 Q2
4 quarters
BEBE icon
815
DELISTED
Bebe Stores Inc
BEBE
$5.93M 0.02%
194,301
-22,731
-10% -$1.05M
2013 Q2
4 quarters
OPY icon
816
Oppenheimer Holdings
OPY
$1.07B
$5.91M 0.02%
246,412
+13,400
+6% +$330K
2013 Q2
4 quarters
MKTX icon
817
MarketAxess Holdings
MKTX
$5.79B
$5.9M 0.02%
109,200
– –
2014 Q1
1 quarter
OSUR icon
818
OraSure Technologies
OSUR
$252M
$5.86M 0.02%
680,821
+155,821
+30% +$1.09M
2013 Q3
3 quarters
ELLI
819
DELISTED
Ellie Mae Inc
ELLI
$5.85M 0.02%
188,000
– –
2013 Q2
4 quarters
EXK icon
820
Endeavour Silver
EXK
$2.46B
$5.83M 0.02%
1,068,600
-60,100
-5% -$268K
2013 Q2
4 quarters
AVHI
821
DELISTED
A V Homes, Inc.
AVHI
$5.77M 0.02%
352,900
– –
2013 Q3
3 quarters
SSI
822
DELISTED
Stage Stores Inc
SSI
$5.76M 0.02%
308,473
-442,827
-59% -$8.87M
2013 Q2
4 quarters
HIBB icon
823
DELISTED
Hibbett, Inc. Common Stock
HIBB
$5.74M 0.02%
106,000
+46,000
+77% +$2.48M
2013 Q3
3 quarters
DAR icon
824
Darling Ingredients
DAR
$9.72B
$5.72M 0.02%
273,500
-19,500
-7% -$393K
2013 Q2
4 quarters
MFA icon
825
MFA Financial
MFA
$668M
$5.68M 0.02%
173,000
– –
2013 Q2
4 quarters

Similar funds

Royce & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
  • Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
  • Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
  • Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
  • Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
  • Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.

Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.